Incyte
INCY
#980
Rank
A$35.38 B
Marketcap
A$173.59
Share price
1.39%
Change (1 day)
6.44%
Change (1 year)

Incyte (INCY) - Total assets

Total assets on the balance sheet as of September 2026 : A$10.57 Billion

According to Incyte's latest financial reports the company's total assets are A$10.57 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Incyte - Total assets on balance sheet (from 2001 to 2024)

Total assets by year

Year Total assets Change
2023-12-31A$9.95 B15.98%
2022-12-31A$8.58 B26.14%
2021-12-31A$6.80 B46.94%
2020-12-31A$4.63 B-5.38%
2019-12-31A$4.89 B30.32%
2018-12-31A$3.75 B27.34%
2017-12-31A$2.94 B29.74%
2016-12-31A$2.27 B64.38%
2015-12-31A$1.38 B42.1%
2014-12-31A$0.97 B37.89%
2013-12-31A$0.70 B121.98%
2012-12-31A$0.31 B-0.9%
2011-12-31A$0.32 B-33.43%
2010-12-31A$0.48 B-39.22%
2009-12-31A$0.79 B140.76%
2008-12-31A$0.32 B4.45%
2007-12-31A$0.31 B-29.7%
2006-12-31A$0.44 B-12.27%
2005-12-31A$0.51 B-23.46%
2004-12-31A$0.66 B30.82%
2003-12-31A$0.51 B-47.9%
2002-12-31A$0.98 B-29.11%
2001-12-31A$1.38 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Novartis
NVS
A$169.95 B 1,507.59%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$291.80 B 2,660.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$214.82 B 1,931.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$138.75 B 1,212.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
A$3.17 B-70.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
A$0.75 B-92.88%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
A$0.16 B-98.46%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
A$0.14 B-98.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
A$0.83 B-92.10%๐Ÿ‡บ๐Ÿ‡ธ USA